Sign up
Pharma Capital

Orgenesis explains the impacts of it's cell therapy development and manufacturing tech

Orgenesis Inc.(NASDAQ:ORGS) CEO Vered Caplan meets Steve Darling of Proactive Investors at the 9th Annual LD Micro Invitational Investor Conference in Los Angeles, CA.

 

View full ORGS profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.